custom-designed microarray platform (Lineagen Inc)
Structured Review
Custom Designed Microarray Platform, supplied by Lineagen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/custom-designed+microarrays/custom+designed+microarray+platform/pm28767196-76-8-7
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Two unrelated children with overlapping 6q25.3 deletions, motor speech disorders, and language delays. Article Snippet: Funding information Arizona State University, Grant number: New Faculty Startup Fund Interstitial and terminal 6q25 deletions are associated with developmental delays, hypotonia, eye pathologies, craniofacial dysmorphologies, and structural brain anomalies.. In most cases, speech and language deficits are not described in detail.. We report on a case (Patient 1, age 7 years) with a de novo 6q25.3-qter deletion, 11.1Mb long and encompassing 108 genes, and a case (Patient 2, age 5 years) with an inherited interstitial 6q25.3 deletion, located within Patient 1’s deletion region and 403 kb long, the smallest 6q25 deletion reported to date. |
